Cosmo Pharmaceuticals Presents Breakthrough Phase III Results for Breezula (Clascoterone)
I have covered the novel androgen receptor antagonist Breezula® (Clascoterone) for 11 years across numerous posts. The product was originally known as CB-03-01, and manufactured by a company named Cassiopea (Italy). The latter was acquired by Cosmo Pharmaceuticals (Ireland) in December 2021. Clascoterone 5% is expected to get approved in the US and EU as … Continue reading Cosmo Pharmaceuticals Presents Breakthrough Phase III Results for Breezula (Clascoterone)